Clinical trial
A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination…
NCT00239187 · OPKO Health, Inc., Industry · Completed
Key facts
| NCT number | NCT00239187 |
|---|---|
| Title | A Study in Type 2 Diabetic Patients With Repeated Doses of E1 in Combination With G1 |
| Official title | A Randomized, Double-blind, Placebo-controlled Clinical Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Clinical Response of Repeated Subcutaneous Doses of E1 in Combination With G1 in Patients With Type 2 Diabetes |
| Lead sponsor | OPKO Health, Inc., Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Type 2 Diabetes |
| Intervention type | Drug |
| Interventions | E1 and G1 |
| Enrollment | 30 |
| Start date | Sep 1, 2005 |
| Completion | Jan 1, 2007 |
| First posted | Oct 14, 2005 |
| Last update posted | Oct 18, 2019 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: